News
J&J adds rare disease wAIHA to Imaavy's potential uses
Johnson & Johnson's 'Swiss army knife' drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.
Tuesday 21 July 2026
